Developer docs
API playgroundTry for free, no card

Search company profiles

Shapiro+Raj

Full company profile

uuid0009mz1

Namestring
Shapiro+Raj
Legal namestring
Leo J. Shapiro & Associates, LLC.
Websiteurl
shapiroraj.com
Company typeenum
Private
Founded yearint
1961
Descriptiontext

Shapiro+Raj is a US-based, privately held strategic insights consultancy focused on the global life sciences industry. Founded in 1961 as Leo J. Shapiro & Associates, LLC and headquartered in Chicago, the firm serves pharmaceutical, biotechnology, and medical-device clients across the commercialization lifecycle — from early pipeline and innovation work through market-shaping strategy, TPP testing, segmentation, positioning, communication testing, and launch execution. It claims partnerships with 8 of the top 10 global biopharmaceutical companies and delivers projects across 12 or more markets including the US, Germany, France, UK, Spain, Japan, and China.

The firm's core technology stack centers on Stella.ai, a proprietary AI agent launched commercially in April 2026 and built specifically for life sciences insights teams. Stella synthesizes primary research, generates digital avatars trained on real respondent data, and supports predictive scenario modeling (e.g., TPP simulator, adoption-curve forecasting via PROsician™). It is wrapped by the TechManity™ methodology, which integrates human social-science expertise, AI, and curated tech (including the MIT-licensed Luminoso engine inside S+R AQuA™) into proprietary frameworks such as WithInsight™ (dual-process System 1/System 2 capture), Fishbowl, and Guided Deliberations™. The firm reports operational outcomes including 25–40% faster path-to-market versus legacy approaches, 6–9+ months saved on lifecycles, and a claimed 87% predictive accuracy across engagements.

Shapiro+Raj operates a hybrid revenue model: traditional project-based strategic consulting engagements remain the core revenue stream, while Stella.ai introduces a platform access layer (potentially subscription or usage-based) targeting mid-size and emerging pharma that require enterprise-grade intelligence without enterprise-scale research budgets. Go-to-market is enterprise sales-led through direct engagement, thought leadership (Perspectives blog, case studies), and industry events, with leadership additions (President Amir Kapadia, CPO Scott Swigart) explicitly tasked with scaling the AI product. The firm is founder/management-controlled under Chairman and CEO Zain Raj, with no disclosed external institutional investment.

Short descriptiontext

Shapiro+Raj is a Chicago-based life sciences strategic insights consultancy serving top global biopharmaceutical companies with proprietary research methodologies and its AI agent Stella.ai.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersChicago, United States
HQ citystring
Chicago
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
strategic insights consulting, pharmaceutical market research, life sciences branding, commercialization strategy, AI insights platform
Industry4 codes
PRIMARYBPAHALAB
Competitive Intelligence & Benchmarking
SECONDARYBPAHALAM
Pricing, Revenue & Commercial Analytics
SECONDARYBPAEAHAK
Industry/Domain Analytics Solutions & Accelerators
SECONDARYBPAHAEAF
Data, Analytics & AI Consulting
NAICS code3 codes
  • Marketing Research and Public Opinion Polling541910
  • Software Publishers51321
  • Professional, Scientific, and Technical Services541
SIC code2 codes
  • Services-Management Consulting Services8742
  • Services-Prepackaged Software7372
Product category
Pharmaceutical Market Research Consulting
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Strategic Insights Consulting Services
TypeProfessional Services
Description

Core revenue from strategic insights consulting for life sciences companies across the pharmaceutical lifecycle. Services include market research, brand strategy, positioning, message testing, patient journey research, TPP testing, and launch execution support. Project-based engagements with pharmaceutical, biotech, and medical device companies.

shapiroraj.com
2Stella.ai Platform Access
TypeSubscription Recurring
Description

Commercial availability of proprietary AI Agent for life sciences marketing and insights. Revenue potentially from platform subscriptions or usage-based access for enterprise teams.

prnewswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 7 records shown
1Stella.ai
Description

Proprietary AI Agent platform built specifically for the life sciences industry, enabling insights teams to connect and interrogate data across their entire ecosystem on demand.

shapiroraj.com
+6 more records
Core offering1 text field

Shapiro+Raj is a life sciences strategic insights consultancy that helps pharmaceutical, biotech, and medical device companies accelerate commercialization through market research, brand positioning, message testing, patient journey mapping, segmentation, TPP testing, and launch strategy. The firm blends behavioral science expertise with its proprietary AI agent Stella.ai and proprietary methodologies (TechManity, PROsician, WithInsight, Fishbowl, Guided Deliberations, S+R AQuA, IdealSpaces) to deliver insights 25-40% faster than legacy approaches.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Lifecycles accelerated 40% faster than legacy approaches
+7 more records
Product overview1 text field

Shapiro+Raj is a life sciences strategic insights consultancy operating as a platform-plus-services model centered on its proprietary AI agent Stella.ai. The core offering combines the TechManity™ methodology framework—which integrates human social science expertise with AI intelligence and continuous data—with specialized research products including Stella.ai (the AI agent platform), Digital Avatars (AI-powered persona simulations), and various proprietary research methodologies (PROsician™, WithInsight™, Guided Deliberations™, Fishbowl, S+R AQuA™). Services span the pharmaceutical lifecycle from early pipeline innovation through market growth, including TPP testing, patient segmentation, brand positioning, message testing, and launch strategy. The company targets pharmaceutical, biotech, and medical device brands seeking accelerated commercialization.

Product and service3 records
1Stella.ai
CategoryAI Insights Platform
Description

Proprietary AI agent built specifically for the life sciences industry that enables insights teams to connect and interrogate data across their entire ecosystem on demand, synthesizing primary research, simulating behaviors via digital avatars, and predicting outcomes with anti-hallucination design. Sold as a platform offering to life sciences marketing and insights teams.

2Strategic Insights Consulting Services
CategoryProfessional Consulting Services
Description

End-to-end strategic insights engagements across the pharmaceutical lifecycle covering early pipeline innovation, market shaping strategy, communication and growth, brand positioning, message testing, patient journey research, TPP testing, segmentation, launch strategy, and tracking/ATU studies for top pharmaceutical, biotech, and medical device companies.

3S+R Future-Casting Roundtables
CategoryResearch Service
Description

Facilitated roundtable sessions bringing together diverse stakeholder perspectives to pressure-test hypotheses, co-create future scenarios, and shape strategic planning for pharmaceutical launches.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierSupportingTypeTechnology or Integration
Description

Licensed AI-enabled text analytic engine from MIT. Used within S+R AQuA™ (Advanced Qualitative Analytics) platform to generate full picture of overt and latent connections in research data with depth and speed. The partnership provides access to MIT-developed natural language understanding technology.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the largest life sciences data, analytics, and commercial insights provider globally. It competes with Shapiro+Raj on strategic insights for top pharma but operates as a broad incumbent across clinical, real-world evidence, and commercial engagements rather than specializing in AI-first pharma insights.

2ZS Associates
TypeDirect peer
Description

ZS Associates is a leading management consulting firm with deep pharma commercial focus, providing strategy, sales, and marketing insights to top-10 pharma. It directly competes with Shapiro+Raj on commercial insights engagements and serves similar enterprise pharma clients.

TypeDirect peer
Description

Trinity Life Sciences is a life sciences strategic insights and analytics firm that competes directly with Shapiro+Raj across TPP testing, patient journey research, brand positioning, and launch strategy for top global pharma.

TypeDirect peer
Description

Prescient Healthcare Group is a pharma strategy consultancy offering commercial insights, competitive intelligence, and brand strategy services. It overlaps with Shapiro+Raj on therapy-area insights, positioning, and market access advisory for mid-size and top-tier pharma.

TypeBroad incumbent
Description

Kantar is a broad market research and consumer insights provider with a dedicated life sciences practice. It competes with Shapiro+Raj on global brand tracking, patient research, and pharma market assessment at a much larger scale.

TypeDirect peer
Description

Syneos Health Consulting provides commercial strategy and insights services to biopharma, including brand strategy, market shaping, and launch readiness. Direct overlap with Shapiro+Raj on commercial insights for pharma brands.

TypeBroad incumbent
Description

DRG, now part of Clarivate, provides life sciences market intelligence, disease insights, and forecasting to pharma. It competes with Shapiro+Raj on therapy-area market assessment and competitive intelligence at a larger, more syndicated scale.

TypeBroad incumbent
Description

Evidera provides health economics, outcomes research, and real-world evidence to biopharma. Adjacent to Shapiro+Raj's commercial insights practice, overlapping on evidence-based decision support for pharma launches.

TypeDirect peer
Description

Lumanity (formerly SHG / Strategic Healthcare Group and Cello Health) provides life sciences consulting and insights. Direct overlap with Shapiro+Raj on commercial strategy, brand positioning, and HCP/patient insights engagements.

TypeEmerging player
Description

Genesis Research is a life sciences evidence and insights consultancy offering strategic insights, real-world evidence, and market access support to pharma. It is a smaller, emerging peer with comparable service lines to Shapiro+Raj's consulting side.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Shapiro+Raj

Pharmaceutical Market Research Consultingshapiroraj.com

Shapiro+Raj is a Chicago-based life sciences strategic insights consultancy serving top global biopharmaceutical companies with proprietary research methodologies and its AI agent Stella.ai.

What Shapiro+Raj does

Shapiro+Raj is a US-based, privately held strategic insights consultancy focused on the global life sciences industry. Founded in 1961 as Leo J. Shapiro & Associates, LLC and headquartered in Chicago, the firm serves pharmaceutical, biotechnology, and medical-device clients across the commercialization lifecycle — from early pipeline and innovation work through market-shaping strategy, TPP testing, segmentation, positioning, communication testing, and launch execution. It claims partnerships with 8 of the top 10 global biopharmaceutical companies and delivers projects across 12 or more markets including the US, Germany, France, UK, Spain, Japan, and China.

The firm's core technology stack centers on Stella.ai, a proprietary AI agent launched commercially in April 2026 and built specifically for life sciences insights teams. Stella synthesizes primary research, generates digital avatars trained on real respondent data, and supports predictive scenario modeling (e.g., TPP simulator, adoption-curve forecasting via PROsician™). It is wrapped by the TechManity™ methodology, which integrates human social-science expertise, AI, and curated tech (including the MIT-licensed Luminoso engine inside S+R AQuA™) into proprietary frameworks such as WithInsight™ (dual-process System 1/System 2 capture), Fishbowl, and Guided Deliberations™. The firm reports operational outcomes including 25–40% faster path-to-market versus legacy approaches, 6–9+ months saved on lifecycles, and a claimed 87% predictive accuracy across engagements.

Shapiro+Raj operates a hybrid revenue model: traditional project-based strategic consulting engagements remain the core revenue stream, while Stella.ai introduces a platform access layer (potentially subscription or usage-based) targeting mid-size and emerging pharma that require enterprise-grade intelligence without enterprise-scale research budgets. Go-to-market is enterprise sales-led through direct engagement, thought leadership (Perspectives blog, case studies), and industry events, with leadership additions (President Amir Kapadia, CPO Scott Swigart) explicitly tasked with scaling the AI product. The firm is founder/management-controlled under Chairman and CEO Zain Raj, with no disclosed external institutional investment.

Shapiro+Raj firmographics

Firmographics
Name
Shapiro+Raj
Legal name
Leo J. Shapiro & Associates, LLC.
Website
https://shapiroraj.com
Company type
Private
Founded year
1961
Operating status
Operating
Headcount range
51–100 employees
Short description
Shapiro+Raj is a Chicago-based life sciences strategic insights consultancy serving top global biopharmaceutical companies with proprietary research methodologies and its AI agent Stella.ai.
Ownership category
akta.pro rank

Shapiro+Raj industry classification

Industry
Product category
Pharmaceutical Market Research Consulting
NAICS
Marketing Research and Public Opinion Polling (541910), Software Publishers (51321), Professional, Scientific, and Technical Services (541)
SIC
Services-Management Consulting Services (8742), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYBPAHALAB
Competitive Intelligence & Benchmarking
SECONDARYBPAHALAM
Pricing, Revenue & Commercial Analytics
SECONDARYBPAEAHAK
Industry/Domain Analytics Solutions & Accelerators
SECONDARYBPAHAEAF
Data, Analytics & AI Consulting

Keywords

  • Strategic insights consulting
  • Pharmaceutical market research
  • Life sciences branding
  • Commercialization strategy
  • AI insights platform

Where Shapiro+Raj is headquartered

Location

Headquarters

HQ city
Chicago
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Shapiro+Raj business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. Strategic Insights Consulting Services: Core revenue from strategic insights consulting for life sciences companies across the pharmaceutical lifecycle. Services include market research, brand strategy, positioning, message testing, patient journey research, TPP testing, and launch execution support. Project-based engagements with pharmaceutical, biotech, and medical device companies.
  2. Stella.ai Platform Access: Commercial availability of proprietary AI Agent for life sciences marketing and insights. Revenue potentially from platform subscriptions or usage-based access for enterprise teams.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Shapiro+Raj product offering

Product offering

Core offering

Shapiro+Raj is a life sciences strategic insights consultancy that helps pharmaceutical, biotech, and medical device companies accelerate commercialization through market research, brand positioning, message testing, patient journey mapping, segmentation, TPP testing, and launch strategy. The firm blends behavioral science expertise with its proprietary AI agent Stella.ai and proprietary methodologies (TechManity, PROsician, WithInsight, Fishbowl, Guided Deliberations, S+R AQuA, IdealSpaces) to deliver insights 25-40% faster than legacy approaches.

Product overview

Shapiro+Raj is a life sciences strategic insights consultancy operating as a platform-plus-services model centered on its proprietary AI agent Stella.ai. The core offering combines the TechManity™ methodology framework—which integrates human social science expertise with AI intelligence and continuous data—with specialized research products including Stella.ai (the AI agent platform), Digital Avatars (AI-powered persona simulations), and various proprietary research methodologies (PROsician™, WithInsight™, Guided Deliberations™, Fishbowl, S+R AQuA™). Services span the pharmaceutical lifecycle from early pipeline innovation through market growth, including TPP testing, patient segmentation, brand positioning, message testing, and launch strategy. The company targets pharmaceutical, biotech, and medical device brands seeking accelerated commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • Stella.ai: Proprietary AI Agent platform built specifically for the life sciences industry, enabling insights teams to connect and interrogate data across their entire ecosystem on demand.
  • TechManity™
  • PROsician™
  • Fishbowl
  • S+R AQuA™
  • WithInsight™
  • IdealSpaces™

Products and services

  • Stella.ai Proprietary AI agent built specifically for the life sciences industry that enables insights teams to connect and interrogate data across their entire ecosystem on demand, synthesizing primary research, simulating behaviors via digital avatars, and predicting outcomes with anti-hallucination design. Sold as a platform offering to life sciences marketing and insights teams.
  • Strategic Insights Consulting Services End-to-end strategic insights engagements across the pharmaceutical lifecycle covering early pipeline innovation, market shaping strategy, communication and growth, brand positioning, message testing, patient journey research, TPP testing, segmentation, launch strategy, and tracking/ATU studies for top pharmaceutical, biotech, and medical device companies.
  • S+R Future-Casting Roundtables Facilitated roundtable sessions bringing together diverse stakeholder perspectives to pressure-test hypotheses, co-create future scenarios, and shape strategic planning for pharmaceutical launches.

Quantifiable outcome

  • Lifecycles accelerated 40% faster than legacy approaches
  • +7 more outcomes

Companies that use Shapiro+Raj

Customer profile

Named customers14 records

Segments4 records

Ideal customer profiles3 records

Shapiro+Raj technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature9 records

Shapiro+Raj partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Luminoso (MIT)supportingTechnology or IntegrationLicensed AI-enabled text analytic engine from MIT. Used within S+R AQuA™ (Advanced Qualitative Analytics) platform to generate full picture of overt and latent connections in research data with depth and speed. The partnership provides access to MIT-developed natural language understanding technology.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Shapiro+Raj competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the largest life sciences data, analytics, and commercial insights provider globally. It competes with Shapiro+Raj on strategic insights for top pharma but operates as a broad incumbent across clinical, real-world evidence, and commercial engagements rather than specializing in AI-first pharma insights.
  • Kantar Health (now part of Cerner/envision): Kantar is a broad market research and consumer insights provider with a dedicated life sciences practice. It competes with Shapiro+Raj on global brand tracking, patient research, and pharma market assessment at a much larger scale.
  • DRG (Decision Resources Group) / Clarivate: DRG, now part of Clarivate, provides life sciences market intelligence, disease insights, and forecasting to pharma. It competes with Shapiro+Raj on therapy-area market assessment and competitive intelligence at a larger, more syndicated scale.
  • Evidera (PPD / Thermo Fisher): Evidera provides health economics, outcomes research, and real-world evidence to biopharma. Adjacent to Shapiro+Raj's commercial insights practice, overlapping on evidence-based decision support for pharma launches.

Direct peers

  • ZS Associates: ZS Associates is a leading management consulting firm with deep pharma commercial focus, providing strategy, sales, and marketing insights to top-10 pharma. It directly competes with Shapiro+Raj on commercial insights engagements and serves similar enterprise pharma clients.
  • Trinity Life Sciences: Trinity Life Sciences is a life sciences strategic insights and analytics firm that competes directly with Shapiro+Raj across TPP testing, patient journey research, brand positioning, and launch strategy for top global pharma.
  • Prescient Healthcare Group: Prescient Healthcare Group is a pharma strategy consultancy offering commercial insights, competitive intelligence, and brand strategy services. It overlaps with Shapiro+Raj on therapy-area insights, positioning, and market access advisory for mid-size and top-tier pharma.
  • Syneos Health Consulting: Syneos Health Consulting provides commercial strategy and insights services to biopharma, including brand strategy, market shaping, and launch readiness. Direct overlap with Shapiro+Raj on commercial insights for pharma brands.
  • Market Research.com / Lumanity: Lumanity (formerly SHG / Strategic Healthcare Group and Cello Health) provides life sciences consulting and insights. Direct overlap with Shapiro+Raj on commercial strategy, brand positioning, and HCP/patient insights engagements.

Emerging players

  • Genesis Research: Genesis Research is a life sciences evidence and insights consultancy offering strategic insights, real-world evidence, and market access support to pharma. It is a smaller, emerging peer with comparable service lines to Shapiro+Raj's consulting side.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Shapiro+Raj social profiles

Digital presence

Shapiro+Raj financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Shapiro+Raj leadership team

Management profile

Number of profiles

Profiles1 record

Shapiro+Raj funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Shapiro+Raj M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Shapiro+Raj

What does Shapiro+Raj do?

Shapiro+Raj is a life sciences strategic insights consultancy that helps pharmaceutical, biotech, and medical device companies accelerate commercialization through market research, brand positioning, message testing, patient journey mapping, segmentation, TPP testing, and launch strategy. The firm blends behavioral science expertise with its proprietary AI agent Stella.ai and proprietary methodologies (TechManity, PROsician, WithInsight, Fishbowl, Guided Deliberations, S+R AQuA, IdealSpaces) to deliver insights 25-40% faster than legacy approaches.

Is Shapiro+Raj a public or private company?

Shapiro+Raj is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Shapiro+Raj founded?

Shapiro+Raj was founded in 1961. It employs 51 to 100 people.

Where is Shapiro+Raj based?

Shapiro+Raj is headquartered in Chicago, United States, in the North America region.

How does Shapiro+Raj make money?

Two revenue lines are on record. Strategic Insights Consulting Services are the primary driver. The others are stella.ai Platform Access.

Who are Shapiro+Raj's main competitors?

Broad incumbents on record are IQVIA, Kantar Health (now part of Cerner/envision), DRG (Decision Resources Group) / Clarivate and Evidera (PPD / Thermo Fisher). Direct peers are ZS Associates, Trinity Life Sciences, Prescient Healthcare Group, Syneos Health Consulting and Market Research.com / Lumanity. Genesis Research is listed as an emerging player.

Does Shapiro+Raj have an API?

No public API is recorded for Shapiro+Raj.

What industry is Shapiro+Raj in?

Shapiro+Raj's product category is Pharmaceutical Market Research Consulting. Its primary akta.pro industry code is BPAHALAB, Competitive Intelligence & Benchmarking, with a secondary code of BPAHALAM, Pricing, Revenue & Commercial Analytics. Its NAICS code is 541910 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsLisa La Brooy Elevates to President at Shapiro+Raj Amidst Rapid GrowthOn July 15, 2026, Shapiro+Raj announced the promotion of Lisa La Brooy to President of the strategic insights consultancy serving the life sciences sector. La Brooy, who brings over 20 years of experience in client-facing roles within life sciences, will focus on the firm's strategic growth agenda, talent development, and delivery excellence. The promotion comes as Shapiro+Raj accelerates its growth, outpacing competitors by integrating human expertise with AI technologies to differentiate itself in the pharmaceutical and biotech consulting space.PR NewswireShapiro+Raj Promotes Lisa La Brooy to President as Firm Accelerates Category-Outpacing GrowthShapiro+Raj, a strategic insights consultancy serving the life sciences industry, announced the promotion of Lisa La Brooy to President, effective immediately. La Brooy brings over 20 years of experience in client-facing insights work and will lead the firm's client organization, strategic growth agenda, talent development, and delivery excellence while continuing to work directly with clients. The appointment supports the firm's next phase of growth as it continues to outpace the broader insights category and scales its human-led, AI-amplified model.PR NewswireShapiro+Raj Launches an AI Agent Built Specifically for the Life Sciences Industry, Appoints Scott Swigart and Amir Kapadia to Lead Its GrowthShapiro+Raj, a life sciences strategic insights consultancy, announced the commercial availability of Stella.ai, its proprietary AI Agent designed for life sciences marketing and insights, along with the appointment of Scott Swigart as Chief Product Officer and Amir Kapadia as President to lead the product's expansion. Stella is built to enable insights teams to connect and interrogate data across their entire ecosystem on demand, addressing the accelerating pace of pharmaceutical commercialization. The company is targeting mid-size and emerging pharma companies that need enterprise-grade intelligence without enterprise-scale research budgets.ShapirorajHealthcare’s Perfect Storm: How Reimbursement Changes Could Reshape Medical Practices in 2025A study by Shapiro+Raj indicates that healthcare providers are deeply concerned about upcoming changes to Medicare, Medicaid, and insurance reimbursements under the new administration, with nearly half fearing significant impacts on their practice finances. These financial pressures are driving independent practices toward consolidation with larger health systems as they struggle with rising operational costs and declining payments. Consequently, pharmaceutical companies are urged to adapt their strategies by engaging with institutional entities and simplifying administrative burdens like prior authorizations to maintain access for patients.PR NewswireThe Provider Perspective: Insights on Policy, Practice, and Patient Care. A Shapiro+Raj Study on the Outlook of US Healthcare ProvidersShapiro+Raj, a Chicago-based insights and strategy consultancy, has released a four-part study titled 'The Provider Perspective: Insights on Policy, Practice, and Patient Care,' examining how healthcare providers across multiple specialties are navigating an evolving policy landscape. The study covers eight specialties including hematologists/oncologists, dermatologists, gastroenterologists, rheumatologists, and neurologists, and explores key themes including reimbursement concerns, access for vulnerable populations, and implications for practice settings. The research aims to equip pharmaceutical companies, payers, and policymakers with strategic insights to align with provider priorities amid anticipated funding and policy changes.YahooShapiro+Raj Unveils Groundbreaking AI Avatar Platform for Consumer InsightsShapiro+Raj launched its interactive AI personas platform, powered by Stella.ai, to provide consumer insights and engagement. The platform enables brands to test creative concepts and refine messaging through AI avatars that mimic real consumer interactions. The company cites reduced time and cost compared to traditional focus groups.PR NewswireShapiro+Raj Launches Stella™: A Pioneering AI Platform Poised to Disrupt Market ResearchShapiro+Raj, a top-five most innovative global insights company, unveiled Stella.ai, an AI platform designed to revolutionize market research by combining advanced large language models and generative AI with social science rigor. The platform can simulate stakeholder feedback, enabling clients to refine content and prioritize innovation without conducting new research, allowing faster decision-making. The launch aligns with Shapiro+Raj's TechManity philosophy, positioning the platform as a strategic tool for Fortune 500 clients to futureproof their segmentation, branding, and innovation agendas.TmcnetShapiro+Raj Revolutionizes Market Research with AI-Powered Insights, Appoints Scott Swigart to Lead New AI Innovation PracticeShapiro+Raj promoted Scott Swigart to head its newly formed Technology Practice + AI Innovation group. Swigart brings over 25 years of experience with tech giants like Amazon and Microsoft. The company aims to deliver faster, more cost-effective insights using AI tools.PR NewswireShapiro+Raj Revolutionizes Market Research with AI-Powered Insights, Appoints Scott Swigart to Lead New AI Innovation PracticeShapiro+Raj promoted Scott Swigart to head its newly formed Technology Practice + AI Innovation group. The company's AI-infused research approach aims to deliver faster, more cost-effective insights for clients. The launch of the AI Innovation Practice is intended to make research projects smarter and more impactful.PR NewswireShapiro+Raj Strengthens and Expands Data Analytics & Insights Capabilities with Hiring of Geneva TaylorShapiro+Raj has appointed Geneva Taylor as Director of Data Analytics & Insights to strengthen its research and insights capabilities. This hire aims to enhance the firm's marketing sciences and predictive analytics offerings for its clients, particularly Fortune 500 companies. The move reflects Shapiro+Raj's strategic focus on integrating big data and advanced modeling into its service delivery.